Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

In this cohort study, midlife hearing loss was linked with smaller brain volumes, faster decline in executive function, and a higher risk of developing dementia, particularly in those carrying the ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at ...

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...

A research team at the University of Pittsburgh, led by Dr. Anne Robertson and PhD candidate Fatemeh Azari, discovered that the bladder does not simply inflate like a balloon when it fills. Instead, ...

Heart disease can develop silently over years, and routine blood tests alone may not reveal hidden risks. Cardiac surgeon Dr.